
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10700490
[patent_doc_number] => 20160046637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/923186
[patent_app_country] => US
[patent_app_date] => 2015-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12197
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14923186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/923186 | Pyrrolo[2,3-D]pyrimidine derivatives as CB2 receptor agonists | Oct 25, 2015 | Issued |
Array
(
[id] => 13702443
[patent_doc_number] => 20170362176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CARBAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/521194
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521194 | Carbazole derivatives | Oct 22, 2015 | Issued |
Array
(
[id] => 13461585
[patent_doc_number] => 20180282335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
[patent_app_type] => utility
[patent_app_number] => 15/521895
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521895
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521895 | RIPK2 inhibitors and method of treating cancer with same | Oct 8, 2015 | Issued |
Array
(
[id] => 11993855
[patent_doc_number] => 20170298008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'TRIFLUOROMETHOXYLATION OF ARENES VIA INTRAMOLECULAR TRIFLUOROMETHOXY GROUP MIGRATION'
[patent_app_type] => utility
[patent_app_number] => 15/516610
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 68988
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516610 | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration | Oct 8, 2015 | Issued |
Array
(
[id] => 12001786
[patent_doc_number] => 20170305941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'Silylated Pyrimidine Prodrugs And Methods Of Their Use'
[patent_app_type] => utility
[patent_app_number] => 15/516653
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7654
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516653
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516653 | Silylated pyrimidine prodrugs and methods of their use | Oct 7, 2015 | Issued |
Array
(
[id] => 10677979
[patent_doc_number] => 20160024124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS FOR SYNTHESIZING METAL MESOPORPHYRINS'
[patent_app_type] => utility
[patent_app_number] => 14/875141
[patent_app_country] => US
[patent_app_date] => 2015-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9518
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/875141 | Methods for synthesizing metal mesoporphyrins | Oct 4, 2015 | Issued |
Array
(
[id] => 10799124
[patent_doc_number] => 20160145281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'NEW IRIDIUM-BASED COMPLEXES FOR ECL'
[patent_app_type] => utility
[patent_app_number] => 14/867074
[patent_app_country] => US
[patent_app_date] => 2015-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11125
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14867074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/867074 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | Sep 27, 2015 | Abandoned |
Array
(
[id] => 11993914
[patent_doc_number] => 20170298070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'NOVEL CHIRAL SYNTHESIS OF N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES'
[patent_app_type] => utility
[patent_app_number] => 15/512919
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9188
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512919
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512919 | NOVEL CHIRAL SYNTHESIS OF N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES | Sep 24, 2015 | Abandoned |
Array
(
[id] => 10654669
[patent_doc_number] => 20160000812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/856761
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61545
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14856761
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/856761 | Azepane derivatives and methods of treating hepatitis B infections | Sep 16, 2015 | Issued |
Array
(
[id] => 10656107
[patent_doc_number] => 20160002252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'SUBSTITUTED PYRROLO[2,3-d]PYRIMIDINES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/854899
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14854899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/854899 | Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders | Sep 14, 2015 | Issued |
Array
(
[id] => 10489654
[patent_doc_number] => 20150374675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION COMPRISING AN APOLIPOPROTEIN PEPTIDE/PHOSPHOLIPID COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 14/852828
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29360
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852828
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/852828 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION COMPRISING AN APOLIPOPROTEIN PEPTIDE/PHOSPHOLIPID COMPLEX | Sep 13, 2015 | Abandoned |
Array
(
[id] => 11858943
[patent_doc_number] => 09738615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Cyclophilin D inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/851835
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 8292
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851835 | Cyclophilin D inhibitors | Sep 10, 2015 | Issued |
Array
(
[id] => 11908201
[patent_doc_number] => 09777006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Inhibitors of leukotriene A4 hydrolase'
[patent_app_type] => utility
[patent_app_number] => 14/849825
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13437
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849825
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849825 | Inhibitors of leukotriene A4 hydrolase | Sep 9, 2015 | Issued |
Array
(
[id] => 11304746
[patent_doc_number] => 09512132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Pyrazole compounds as CB2 agonists'
[patent_app_type] => utility
[patent_app_number] => 14/844991
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15910
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844991 | Pyrazole compounds as CB2 agonists | Sep 2, 2015 | Issued |
Array
(
[id] => 13399853
[patent_doc_number] => 20180251469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => Carbon Dioxide Sensing Compounds
[patent_app_type] => utility
[patent_app_number] => 15/757081
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757081 | Carbon Dioxide Sensing Compounds | Sep 2, 2015 | Abandoned |
Array
(
[id] => 10483255
[patent_doc_number] => 20150368274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'Pyridopyrimidine Or Pyrimidopyrimidine Compound, Prepration Method, Pharmaceutical Composition, And Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/842682
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13090
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842682 | Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereof | Aug 31, 2015 | Issued |
Array
(
[id] => 10483175
[patent_doc_number] => 20150368194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'System and Method for Fluoralkylated Fluorophthalocyanines with Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols'
[patent_app_type] => utility
[patent_app_number] => 14/840640
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 14178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840640
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840640 | System and Method for Fluoralkylated Fluorophthalocyanines with Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols | Aug 30, 2015 | Abandoned |
Array
(
[id] => 10483223
[patent_doc_number] => 20150368242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'NOVEL TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/838419
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22276
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838419
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838419 | NOVEL TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVE | Aug 27, 2015 | Abandoned |
Array
(
[id] => 11230945
[patent_doc_number] => 09458165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'DOT1L inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/838142
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 10434
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838142
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838142 | DOT1L inhibitors | Aug 26, 2015 | Issued |
Array
(
[id] => 10706783
[patent_doc_number] => 20160052930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'AMINOPYRIMIDINYL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/829753
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53864
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829753
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/829753 | Aminopyrimidinyl compounds | Aug 18, 2015 | Issued |